Which Is The Better Buy? AbbVie Or Pfizer

There's no question that AbbVie (NYSE:ABBV) shareholders have been happier campers than Pfizer (NYSE:PFE) shareholders in recent years. Whether you compare the two drug stocks over five years, three years, one year, or so far in 2017, AbbVie stock has outperformed Pfizer.

But, as the statements read on mutual fund, past performance is no guarantee of future results. Which stock is the better pick for long-term investors now? Here's how AbbVie and Pfizer compare.

Back to news